SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012074
Filing Date
2024-08-13
Accepted
2024-08-13 17:10:11
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20240630x10q.htm   iXBRL 10-Q 1567493
2 EX-31.1 fencf-20240630xex31d1.htm EX-31.1 13956
3 EX-31.2 fencf-20240630xex31d2.htm EX-31.2 18535
4 EX-32.1 fencf-20240630xex32d1.htm EX-32.1 9368
5 EX-99.1 fencf-20240630xex99d1.htm EX-99.1 213527
6 GRAPHIC fencf-20240630xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001558370-24-012074.txt   7117295

Data Files

Seq Description Document Type Size
7 EX-101.SCH fencf-20240630.xsd EX-101.SCH 50605
8 EX-101.CAL fencf-20240630_cal.xml EX-101.CAL 36659
9 EX-101.DEF fencf-20240630_def.xml EX-101.DEF 202466
10 EX-101.LAB fencf-20240630_lab.xml EX-101.LAB 333807
11 EX-101.PRE fencf-20240630_pre.xml EX-101.PRE 314619
65 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20240630x10q_htm.xml XML 1299697
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 241202876
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)